Page results
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
This page tells you about the procedure known as a renal cryoablation. It explains what is involved and what the possible risks are.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
File results
-
FOI/2023/0617 - Neonatal unit CCTV
-
FOI/2023/0623 - BMA rate card rates
-
FOI/2023/0635 - Redundancy consultation
-
FOI/2023/0637 - Trust’s policy/eligibility for treatment at Eastman Dental Hospital
-
FOI/2023/0647 - Radiation Protection Supervisor
-
FOI/2023/0648 - Robotic Process Automation (RPA)
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service